FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss
The Food and Drug Administration is warning that popular obesity drugs—including Ozempic, Wegovy, Zepbound, and Mounjaro—may carry a “potential increased risk” of a rare eye condition that can lead to…